Discovery of broad-spectrum high-affinity peptide ligands of spike protein for the vaccine purification of SARS-CoV-2 and Omicron variants

被引:0
|
作者
Ma, Jing [1 ]
Huang, Yongdong [4 ,5 ]
Jia, Guodong [6 ]
Dong, Xiaoyan [1 ,2 ,3 ]
Shi, Qinghong [1 ,2 ,3 ]
Sun, Yan [1 ,2 ,3 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300350, Peoples R China
[2] Tianjin Univ, Key Lab Syst Bioengn, Tianjin 300350, Peoples R China
[3] Tianjin Univ, Minist Educ, Frontiers Sci Ctr Synthet Biol, Tianjin 300350, Peoples R China
[4] Chinese Acad Sci, State Key Lab Biochem Engn, Beijing 100190, Peoples R China
[5] Chinese Acad Sci, Key Lab Biopharmaceut Preparat & Delivery, Beijing 100190, Peoples R China
[6] OBiO Tech Co Ltd, Shanghai 200120, Peoples R China
关键词
Peptide ligand; Broad-spectrum; Phage display; SARS-CoV-2; Molecular dynamics simulation; Vaccine; Affinity chromatography; MONOCLONAL-ANTIBODY; SOFTWARE NEWS; GPU NODES; GROMACS; DOCKING; DESIGN; ENTRY; BANG;
D O I
10.1016/j.ijbiomac.2024.137059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To combat with emerging SARS-CoV-2 variants of concern (VOCs), we report the identification of a set of unique HWK-motif peptide ligands for the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein from a phage-displayed peptide library. These HWK-motif peptides exhibited nanomolar affinity for RBD. Among them, the peptide, HWKAVNWLKPWT (SP-HWK), had not only the highest affinities for RBD and trimer S protein, but also broad-spectrum affinities for RBDs from VOCs. Molecular dynamics simulations and competitive ELISA revealed a conserved pocket between the cryptic and the outer faces of RBD for SP-HWK binding, distinct from the human angiotensin-converting enzyme 2 receptor binding site. By coupling SP-HWK to agarose gel, the as- prepared affinity gel could efficiently capture RBD and trimer S from the ancestral strain and the Omicron variant, and the bound targets could be recovered by mild elution at pH 6.0. More importantly, the affinity gel presented excellent and stable chromatographic performance in the purification of inactivated SARS-CoV-2 and Omicron vaccines, affording high yields and purities, and strong HCP reduction. The results demonstrated the potential of SP-HWK as a broad-spectrum peptide ligand for developing a universal platform for the vaccine purification of SARS-CoV-2 and VOCs.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Identification of a Pentasaccharide Lead Compound with High Affinity to the SARS-CoV-2 Spike Protein via In Silico Screening
    Li, Binjie
    Zhang, Tianji
    Cao, Hui
    Ferro, Vito
    Li, Jinping
    Yu, Mingjia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [42] Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches
    Parmar, Meet
    Thumar, Ritik
    Sheth, Jigar
    Patel, Dhaval
    STRUCTURAL CHEMISTRY, 2022, 33 (06) : 2243 - 2260
  • [43] Enhanced Surface Accessibility of SARS-CoV-2 Omicron Spike Protein Due to an Altered Glycosylation Profile
    Wang, Dongxia
    Zhang, Zijian
    Baudys, Jakub
    Haynes, Christopher
    Osman, Sarah H.
    Zhou, Bin
    Barr, John R.
    Gumbart, James C.
    ACS INFECTIOUS DISEASES, 2024, 10 (06): : 2032 - 2046
  • [44] Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes
    Guerin, Patrick
    Yahi, Nouara
    Azzaz, Fodil
    Chahinian, Henri
    Sabatier, Jean-Marc
    Fantini, Jacques
    MOLECULES, 2022, 27 (12):
  • [45] Spectroscopic investigation on the affinity of SARS-CoV-2 spike protein to gold nano-particles
    Yokoyama, Kazushige
    Ichiki, Akane
    COLLOID AND INTERFACE SCIENCE COMMUNICATIONS, 2021, 40
  • [46] A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera
    Seephetdee, Chotiwat
    Bhukhai, Kanit
    Buasri, Nattawut
    Leelukkanaveera, Puttipatch
    Lerdwattanasombat, Pat
    Manopwisedjaroen, Suwimon
    Phueakphud, Nut
    Kuhaudomlarp, Sakonwan
    Olmedillas, Eduardo
    Saphire, Erica Ollmann
    Thitithanyanont, Arunee
    Hongeng, Suradej
    Wongtrakoongate, Patompon
    ANTIVIRAL RESEARCH, 2022, 204
  • [47] Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2
    Limonta, Daniel
    Dyna-Dagman, Lovely
    Branton, William
    Mancinelli, Valeria
    Makio, Tadashi
    Wozniak, Richard W.
    Power, Christopher
    Hobman, Tom C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (08)
  • [48] A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection
    Perez, Patricia
    Lazaro-Frias, Adrian
    Zamora, Carmen
    Sanchez-Cordon, Pedro J.
    Astorgano, David
    Luczkowiak, Joanna
    Delgado, Rafael
    Casasnovas, Jose M.
    Esteban, Mariano
    Garcia-Arriaza, Juan
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [49] In silico design of multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike protein
    Mitra, Debarghya
    Pandey, Janmejay
    Jain, Alok
    Swaroop, Shiv
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (11) : 5189 - 5202
  • [50] Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
    Wang, Lin
    Wu, Yan
    Yao, Sheng
    Ge, Huan
    Zhu, Ya
    Chen, Kun
    Chen, Wen-zhang
    Zhang, Yi
    Zhu, Wei
    Wang, Hong-yang
    Guo, Yu
    Ma, Pei-xiang
    Ren, Peng-xuan
    Zhang, Xiang-lei
    Li, Hui-qiong
    Ali, Mohammad A.
    Xu, Wen-qing
    Jiang, Hua-liang
    Zhang, Lei-ke
    Zhu, Li-li
    Ye, Yang
    Shang, Wei-juan
    Bai, Fang
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (04) : 788 - 796